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Other names: - 
Location: 17q25.3 with 5’ end towards the centromere. 
Nucleotide 203731-2061912 of contig NT_010663 
Local order: Located telomeric to the BROV region. 
Centromeric to LRRC45 - Rac3 - DCXR telomeric 
DNA/RNA 
Note: 6 exons, spread out over approximately 2.4 kb 
Description 
The Rac3 gene encompasses 6 exons on chromosome 
17. Exon 1 encodes residues 1-12, exon 2 residues 13-
36, exon 3 residues 37-75, exon 4 residues 76-96, exon
5 residues 97-149 and exon 6 residues 150-192. 
Transcription 
Human Rac3 mRNA is a single species of around 1 kb. 
No splice variants have been reported. Factors that 
would regulate gene expression on a transcriptional 
level have not yet been reported. 
Pseudogene 
No pseudogenes of Rac3 are reported in human. 
Protein 
Note: The Rac3 gene encodes a single protein of 192 




Schematic representation of the Rac3 protein (not to scale). Mutations that generate mutants that are locked in a certain conformation - 
constitutively active or dominant negative - are shown. The C-terminal end contains the CTVM motif that is post-translationally modified 
the three last amino acid residues are removed and the C residue is geranyl-geranylated. 
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Description 
Rac3 is a small 21 kDa GTPase that acts as a molecular 
switch. In its active form, it is bound to GTP, whereas 
it is inactive in its GDP-bound form. Racs are 
controlled by guanidine activating proteins (GEFs) that 
exchange bound GDP for GTP and by GTPase 
activating proteins (GAPs) that promote GTP 
hydrolysis. Because of the hydrophobic isoprenyl 
moiety at the C-terminal end, it is associated with 
membranes. In the cytoplasm it associates with the 
chaperone RhoGDI. 
Expression 
Rac3 mRNA was reported in human cell lines 
including GM04155 (lymphoblastic leukemia), K562 
(CML), 5838 (Ewing sarcoma), HL60 (promyelocytic 
leukemia) and DU4475 (breast cancer). Rac3 
expression was reported using semi-quantitative 
RT/PCR in gastric tumor and adjacent normal tissue as 
well as gastric cancer cell lines. Expression of Rac3 
using RT/PCR (38 cycles) was reported in human 
brain, liver, kidney and pancreas poly A RNA and also 
19% of brain tumors expressed Rac3 mRNA. Rac3-
specific polyclonal antibodies were used to show Rac3 
protein in the brain (deep cerebellar nuclei and the
pons) in 7 day old mice. Low level expression of 
mouse rac3 has been reported in bone-marrow-derived 
monocytes and in B-lineage lymphoblasts using 
standard and RealTime RT/PCR. 
Localisation 
The Rac3 protein is located on endomembranes and 
cell membranes. 
Function 
Rac proteins regulate a variety of functions including 
cytoskeletal organization, cell cycle, reactive oxygen 
species production, and vesicle trafficking. In cultured 
cells they also are involved in cellular transformation. 
Studies of null mutant Rac3 mice showed that Rac3 
regulates cerebellar functions and in a mouse model 
plays a role in leukemia development caused by the 
Bcr/Abl oncogene. Point mutations (N26D, F37L, 
Y40C, N43D) were introduced into different critical 
residues of the effector domain of Rac3 and the effcts 
of these were investigated on the ability of Rac3 to 
regulate membrane ruffles, c-jun activation and 
transformation. Transformation was assayed as the 
ability to cooperate with activated Raf in focus 
formation of NIH3T3 cells and the ability to promote 
growth of these cells in soft agar. 
Homology 
Rac3 is most closely related to Rac1 and Rac2. On a 
nucleotide level human Rac3 has 77% identity with 
Rac1, 83% identity with Rac2 and 69% identity with 
RhoG. On an amino acid level, Rac3 and Rac1 differ in 
14/192 residues (92% identical), whereas Rac3 and 
Rac2 differ in 22/192 residues (89% identical). Rac 
belongs to the extended Rho family of small G-




Note: Using in situ hybridization, Rac3 was reported to 
lies outside of the BROV region commonly deleted in 
Breast and Ovarian Cancer. 
Activated Rac3 protein was reported in MDA-435, 
T47D and MCF7 breast cancer cell lines and 1 of 3 
patient samples using a GST-Pak pull-down assay to 
detect activated Rac. 
siRNA against Rac3 inhibits SNB19 glioblastoma and 
BT549 breast cancer cell line invasion in an in vitro 
assay. 
It was showed that introduction of a constitutively 
active Rac3 into the MDA-MB-435 breast cancer cell 
line caused increased invasion and motility in vitro. 
Transgenic mice with tissue specific expression of 
constitutively active (V12)Rac3 in the mammary gland 
were generated. Post-lactational female mice had 
delayed involution. 
Gastric cancer 
Note: Semi-quantitative RT/PCR was used to examine 
Rac3 mRNA expression in gastric cancer tissues and 7 
gastric cell lines. Rac3 expression was detected in the 
tumor samples but there was no statistically significant 
difference between the expression levels in gastric 
cancer and adjacent non-tumorous tissues. The cell 
lines had a varying but detectable Rac3 expression. 
Brain tumors 
Note: RT-PCR was used to evaluate Rac3 mRNA 
expression in human brain tumor tissues. Expression of 
rac3 was reported in 3/9 meningiomas, 1/11 
astrocytomas, 1/6 pituitary adenomas. The PCR 
fragments were subcloned and sequenced, and 
mutations were reported in Rac3 in 12/19 brain tumors 
including E10V, V14E, D35N, P35S, N43D, V46A, 
D57V, R57P, L67V, S83F, V85A, E100G, H104L, 
P109H, R120H, T125P, S158P, P180T, V182E, 
V182A, H184L and G186E. 
To be noted 
Note: There is a second gene that is named RAC3 in 
some publications. This protein is functionally and 
structurally unrelated to the small GTPase Rac3. This is 
the steroid receptor coactivator-3, or nuclear receptor 
coactivator SRC-3/AIB1/ACTR/pCIP/RAC3/TRAM-1. 
Probes 1-12 from NM_005052-links-probes  
1: ProbeTaqMan gene expression (TaqMan) probe 
Hs00414037_g1 for Homo sapiens gene ras-related C3 
botulinum toxin substrate 3 (rho family, small GTP 
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binding protein Rac3) (RAC3). Developed for real time 
qRT-PCR gene expression profiling. Reagent is 
available from Applied Biosystems. 
2: ProbeSmall interfering RNA (siRNA) probe for 
Homo sapiens gene ras-related C3 botulinum toxin 
substrate 3 (rho family, small GTP binding protein 
Rac3) (RAC3). Has been used for RNA interference 
(RNAi). Reference Chan et al., 2005  
3: ProbeSmall interfering RNA (siRNA) probe for 
Homo sapiens gene ras-related C3 botulinum toxin 
substrate 3 (rho family, small GTP binding protein 
Rac3) (RAC3). Has been used for RNA interference 
(RNAi). Reference Chan et al., 2005  
4: ProbeResequencing amplicon (RSA) probe 
RSA001057586 for Homo sapiens gene ras-related C3 
botulinum toxin substrate 3 (rho family, small GTP 
binding protein Rac3) (RAC3). Developed for SNP 
discovery. 
5: ProbeResequencing amplicon (RSA) probe 
RSA001057592 for Homo sapiens gene ras-related C3 
botulinum toxin substrate 3 (rho family, small GTP 
binding protein Rac3) (RAC3). Developed for SNP 
discovery. 
6: ProbeResequencing amplicon (RSA) probe 
RSA001229136 for Homo sapiens genes ras-related C3 
botulinum toxin substrate 3 (rho family, small GTP 
binding protein Rac3) (RAC3) and leucine rich repeat 
containing 45 (LRRC45). Developed for SNP 
discovery. 
7. ProbeResequencing amplicon (RSA) probe 
RSA001400685 for Homo sapiens genes ras-related C3 
botulinum toxin substrate 3 (rho family, small GTP 
binding protein Rac3) (RAC3) and leucine rich repeat 
containing 45 (LRRC45). Developed for SNP 
discovery. 
8: ProbeResequencing amplicon (RSA) probe 
RSA001401207 for Homo sapiens genes ras-related C3 
botulinum toxin substrate 3 (rho family, small GTP 
binding protein Rac3) (RAC3) and leucine rich repeat 
containing 45 (LRRC45). Developed for SNP 
discovery. 
9: ProbeResequencing amplicon (RSA) probe 
RSA001457703 for Homo sapiens gene ras-related C3 
botulinum toxin substrate 3 (rho family, small GTP 
binding protein Rac3) (RAC3). Developed for SNP 
discovery. 
10: ProbeResequencing amplicon (RSA) probe 
RSA001457859 for Homo sapiens gene ras-related C3 
botulinum toxin substrate 3 (rho family, small GTP 
binding protein Rac3) (RAC3). Developed for SNP 
discovery. 
11: ProbeResequencing amplicon (RSA) probe 
RSA001458006 for Homo sapiens gene ras-related C3 
botulinum toxin substrate 3 (rho family, small GTP 
binding protein Rac3) (RAC3). Developed for SNP 
discovery. 
 
12: ProbeResequencing amplicon (RSA) probe 
RSA001458005 for Homo sapiens gene ras-related C3 
botulinum toxin substrate 3 (rho family, small GTP 
binding protein Rac3) (RAC3). Developed for SNP 
discovery. 
13: Chan et al. (2005) reported TaqMan primers useful 
in quantifying human Rac3 expression. 
14: Pan et al. (2004) reported primers for semi-
quantitative RT/PCR for human Rac3 that yielded a 
249 bp  
15: Hwang et al. (2005) reported primers for RT-PCR 
of human RNA. Fw primer was 5’-
AATTCATGCAGGCCATCAAGT-3’ and the reverse 
primer 5’-CTAGAAGACGGTGCACTT-3’. 
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